JMP Securities Reiterates Market Outperform on Prothena Corp, Maintains $82 Price Target
Portfolio Pulse from richadhand@benzinga.com
JMP Securities analyst Jason Butler has reiterated a 'Market Outperform' rating on Prothena Corp (NASDAQ:PRTA) and maintained a price target of $82.
July 11, 2023 | 11:50 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Prothena Corp's stock rating has been reiterated as 'Market Outperform' by JMP Securities, with a maintained price target of $82.
The reiteration of the 'Market Outperform' rating and the maintenance of the $82 price target by JMP Securities indicates a positive outlook for Prothena Corp. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100